Company intelligence / Profile preview

KSV Global

West Palm Beach, Florida, USA

Ownership: Private
Development stage: Phase 3

Overview

KSV Global is a growth-stage investment firm with a focus on scaling and transforming companies across consumer, healthcare, and technology sectors. It partners with entrepreneurs for transformative growth and leverages global networks for cross-border opportunities. The firm does not conduct clinical trials or have its own clinical results[1][3].

Therapeutic areas: Other
Modalities: Not applicable (as an investment firm, not a therapeutic developer)
Industry: Investors

Drug pipeline

4 assets

CNM-Au8

Phase 3

Indications: Multiple Sclerosis, Parkinson's Disease, Amyotrophic Lateral Sclerosis

3 more assets in the full pipeline.

Request access →

Partnerships

No major pharmaceutical or biotech partnerships disclosed; acts as an investor rather than operator[1][3].

Beyond the preview

Go deeper on KSV Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KSV Global.

Explore the full profile